Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADVERITAS LIMITED Director's Dealing 2021

Oct 7, 2021

64465_rns_2021-10-07_10e4c484-0d28-4989-8ce5-b5705e0f31f5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity ADVERITAS LIMITED ABN 88 156 377 141

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Stephen Frank Belben

Date of last notice 22 September 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. SF Belben & PJ Belben <Belben SuperFund A/C>- trustee and beneficiary ofaccount.
Date of change 7 October 2021
No. of securities held prior to change SF Belben & PJ Belben <Belben SuperFund A/C>720,000 Fully paid ordinary shares.90,000 quoted options exercisable at $0.10on or before 25/10/2021.SF Belben <Belben Family A/C>750,000 unquoted options exercisable at$0.20, expiring 27/3/2022.1,250,000 unquoted options exercisable at$0.15, expiring 3/7/2023.
Class Fully paid ordinary shares.Quoted options exercisable at $0.10 on orbefore 25/10/2021.
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired 90,000 fully paid ordinary shares.
Number disposed 90,000 quoted options exercisable at $0.10on or before 25/10/2021.
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.10 each
No. of securities held after change SF Belben & PJ Belben <Belben SuperFund A/C>810,000 Fully paid ordinary shares.SF Belben <Belben Family A/C>750,000 unquoted options exercisable at$0.20, expiring 27/3/2022.1,250,000 unquoted options exercisable at$0.15, expiring 3/7/2023.
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back Exerciseof90,000quotedoptionsexercisableat$0.10onorbefore25/10/2021 into 90,000 fully paid ordinaryshares.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed No
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3